Developers: | Activ Surgical |
Date of the premiere of the system: | July, 2020 |
Branches: | Pharmaceutics, medicine, health care |
2020: The announcement of the platform increasing the accuracy of transactions of robots surgeons
In the middle of July, 2020 the Boston startup of Activ Surgical issued the platform which increases the accuracy of transactions of robots surgeons. For further development and optimization the startup attracted $15 million the venture funding, including from such companies as LRVHealth, DNS Capital, GreatPoint Ventures, Tao Capital Partners and Rising Tide VC.
The Activ Surgical ActivEdge platform uses the data obtained from special surgical instruments. All of them are equipped with the sensors created by the company which collect and transfer data in real time during the transaction. Then this information is used for machine learning of algorithms and creation of visualization on the basis of AI which can serve as the management for surgeons and the surgical systems. Such recommendations should reduce the probability of potential errors and finally improve results of treatment.
The main objective of the company - to introduce technology innovations to the sphere of surgical visualization which still relies mainly on such ancient methods as use of fluorescent dyes. Activ Surgical considers that the specialized algorithms using computer vision should provide to surgeons a full-fledged picture about the transaction course, and in the future and to conduct them independently.
ActivSight is the first product of the company within the ActivEdge platform which represents the small connected imagery module. It can be attached to the existing laparoscopic and arthroscopic surgical instruments for visualization. The company waits for permission of regulatory bodies for use of new tools in the fourth quarter 2020 and carries out pilot tests in eight hospitals of the USA.[1]